[ Hotline - 10633 ]

Dr. Ferdous Ara Begum
Make Appointment
  • MBBS

    DCH (Diploma In Child Health)


    MD (Medical Oncology)

  • Associate Professor(Rtd) , National Institute of Cancer Research & Hospital

Dr. Ferdous Ara Begum

Associate Professor(Rtd) , National Institute of Cancer Research & Hospital
  • 15 Days observational training at NUH, Singapore, Department of Medical Oncology.
  •  Attend National and International Conference like BCC, DHNCC, BBCC, World Lung Cancer Conference (WLCC).
Research & Publication
  • Comparison Study of Three Different Platinum Based Combination Chemotherapy in Advanced (Inoperable Stage-III & IV) Non-Small Cell Lung Cancer at NICRH.
  • Comparison of 70 Gy 3DCRT with Concurrent Chemotherapy versus Conventional 66 Gy Radiotherapy with Concurrent. Chemotherapy in Locally Advanced Squamous Cell Carcinoma of Larynx. Shafatujjahan, Chowdhury Q Islam J, Chowdhury MMR, Begum FA, Saha CK (2016) Adv Cancer Prev 1:105. Doi:10.4172/2472-0429.1000105.
  • Platinum-based Therapy with Gemcitabine or Docetaxel in Advanced Non-Small Cell Lung Cancer: A retrospective analysis to evaluate differences in response due to Ethnicity: Qamruzzaman Chowdhury, Salim Reza, Arifur Rahman, Latifa Sultan, Ferdous A. Begum, Fariah Sharmeen, Md. Nurunnabi, A.S.M.F.K Chowdhury, Daud H. Khan.
  •  Application of anti-oxidative Nutritional Support to alleviate Radiotherapy induced toxicities in cervical Cancer patients: Qamruzzaman Chowdhury, A. Hai, M. A. Khaled, F. Elahi, K. J. Maula, F. A. Begum, Hosna A. Sompa, M. Manirul Islam: Bangladesh Journal of MEDICAL SCIENCE, Vol. 08, No.02, P-79-83, September 2002.
  • Chemotherapy
  • Immunotherapy
  • Palliative care management
  •  Patient counselling
Previous Experience
  • 4 year’s experience in Pediatric Medicine.
  • More than 10 year’s working experience in Medical Oncology.